President Trump grew frustrated with HHS Secretary Alex Azar over healthcare polling and vaping involvement; a top Chinese scientist confirms that humans can transmit new coronavirus; coal plant closures were shown to save over 26,000 lives from 2005 to 2016.
Last Thursday, President Trump lashed out at HHS Secretary Alex Azar after senior aides revealed that voters prefer Democrats on healthcare, as reported by Politico. The president expressed frustration that voters have not rewarded his actions in lowering drug prices, while also reportedly expressing regret over his involvement in vaping policy. Axios reports that trying to find a compromise between public health groups and the pro-vaping community has caused political unrest, and although President Trump did not regret the specific vaping policy outcome, he regretted his involvement in an issue that could have been dealt with by the FDA.Zhong Nanshan, MD, a prominent Chinese scientist, confirmed that the mysterious coronavirus that has killed at least 4 people and infected more than 200 in China is capable of being transmitted from person to person, according to The New York Times. The World Health Organization announced yesterday that it was convening an emergency meeting this Wednesday to determine whether the outbreak warrants a public health emergency of international concern and what steps can be employed to manage the virus.In a study published this month in the journal Nature Sustainability, researchers estimate that the shutdown of coal-fired units between 2005 and 2016 has saved 26,610 lives and 570 million bushels of corn, soybeans, and wheat across the areas where the plants closed, according to the Los Angeles Times. Additionally, plants that have remained open were reported to contribute to more than 329,000 premature deaths and the loss of 10.2 billion bushels of crops, nearly half the production in a typical year for US agriculture.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
2 Commerce Drive
Cranbury, NJ 08512